Press release
Male Hypogonadism Market Growth Accelerates: Strategic Forecast Predicts $5.08 Billion by 2029
Male Hypogonadism
What Will the Male Hypogonadism Industry Market Size Be by 2025?
The market for male hypogonadism has seen robust growth in the past few years. It is projected to expand from a size of $3.75 billion in 2024 to $3.99 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Reasons for this growth during the historical period include an aging population, increased awareness and diagnosis, lifestyle factors, chronic diseases, and patterns in seeking treatment.
What's the Long-Term Growth Forecast for the Male Hypogonadism Market Size Through 2029?
The market for male hypogonadism is anticipated to witness significant expansion in the coming years, reaching a value of $5.08 billion by 2029, with a compound annual growth rate (CAGR) of 6.2%. The factors leading to this growth during the forecast period include increased awareness, the incidence of lifestyle-related diseases, advancements in therapy, importance given to men's health, telemedicine, and healthcare accessibility. Noteworthy trends forecasted for this period involve emphasis on mental and sexual health, investigation into nutraceuticals and lifestyle adjustments, growth of the market in developing economies, partnerships in research initiatives, and attention to safety and long-term monitoring.
View the full report here:
https://www.thebusinessresearchcompany.com/report/male-hypogonadism-global-market-report
What Are the Key Growth Drivers Fueling the Male Hypogonadism Market Expansion?
Expectations are high for the growth of the male hypogonadism market due to the rising infertility rates. Infertility is a condition that impairs the reproductive system in men and women, marked by the inability to achieve conception despite having frequent, unprotected intercourse for a year or more. Male hypogonadism, which could result in reduced sperm production and infertility, ranks among the probable causes of male infertility. Hence, the escalating incidence of male infertility could fuel the expansion of the male hypogonadism market. For example, the UK government's Office for National Statistics reported in February 2024 that the total fertility rate (TFR) in 2022 rose to 1.49 children per woman, up from 1.55 in the previous year. Consequently, the rise in infertility rates is propelling the advancement of the male hypogonadism market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9969&type=smp
What Are the Key Trends Driving Male Hypogonadism Market Growth?
A key trend gaining traction in the male hypogonadism market is product innovation. To maintain their market standing, firms in this sector are introducing novel products. For example, Halozyme, an American biotech firm, unveiled Tlando in June 2022. This oral therapy is designed for testosterone replacement in men suffering from hypogonadism. Tlando, a prescription medication containing testosterone, has the distinction of being the first orally administered testosterone treatment to receive FDA approval. It offers a solution for adult males suffering from low to nonexistent testosterone levels due to certain health conditions.
How Is the Male Hypogonadism Market Segmented?
The male hypogonadism market covered in this report is segmented -
1) By Type: Klinefelters Syndrome, Kallmann Syndrome, Pituitary Disorders, Other Types
2) By Drug Delivery: Topical Gels, Injectables, Transdermal Patches, Other Drug Deliveries
3) By Therapy: Testosterone Therapy, Gonadotropin-Releasing Hormone Therapy
Subsegments:
1) By Klinefelter's Syndrome: 47,XXY Syndrome, Other Variants
2) By Kallmann Syndrome: Isolated Kallmann Syndrome, Syndromic Kallmann Syndrome
3) By Pituitary Disorders: Hypopituitarism, Pituitary Tumors, Other Pituitary Disorders
4) By Other Types: Androgen Insensitivity Syndrome, Testicular Dysgenesis Syndrome, Genetic Mutations And Disorders
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9969&type=smp
Which Companies Are Leading the Charge in Male Hypogonadism Market Innovation?
Major companies operating in the male hypogonadism market include Pfizer Inc., Bayer AG, Eli Lilly and Company Ltd., Endo International plc., Merck & Co. Inc., Ferring Pharmaceuticals, Finox Biotech AG, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Perrigo Company plc, IBSA Institut Biochimique SA, Sun Pharmaceutical Industries Limited, Glenmark Pharmaceuticals Limited, Antares Pharma Inc., Zydus Cadila LLC, Besins Healthcare Ltd., Clarus Therapeutics Holdings Inc., Foresee Pharmaceuticals Co. Ltd., Lipocine Inc., Myovant Sciences Ltd., Sandoz International GmbH, Shionogi & Co. Ltd., TherapeuticsMD Inc., Viking Therapeutics Inc.
Which Regions Are Leading the Global Male Hypogonadism Market in Revenue?
North America was the largest region in the male hypogonadism market in 2024. Asia-Pacific is expected to be the fastest-growing region in the male hypogonadism market report during the forecast period. The regions covered in the male hypogonadism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9969
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Male Hypogonadism Market Growth Accelerates: Strategic Forecast Predicts $5.08 Billion by 2029 here
News-ID: 4089499 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Male
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism refers to a medical condition in which the male body is unable to produce adequate levels of testosterone, the hormone responsible for the development and maintenance of male sexual characteristics. This condition can have a significant impact on a man's physical and emotional health, including reduced muscle mass, decreased bone density, and decreased
The male hypogonadism market encompasses the pharmaceuticals and therapies used to treat this condition. The…
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The Male Hypogonadism Market is an emerging segment in the medical industry. This condition affects millions of men around the world and can have serious implications for their physical and mental health. Treatment options are available to help manage symptoms, but often come with associated side effects. The Male Hypogonadism Market is expected to experience significant growth over the coming years as more therapies become available. Pharmaceutical companies are investing…
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
The male hypogonadism market is a segment of the larger pharmaceutical industry that is focused on developing treatments for male hypogonadism, a condition in which the testes do not produce enough testosterone. In 2022, the male hypogonadism market is expected to continue to grow, driven by the increasing prevalence of the condition and the development of new treatments. The market is expected to be worth billions of dollars in 2022, with strong…
Global Male Hypogonadism Market 2023: North America to Remain Largest Market for …
Male hypogonadism is a condition in which the body does not produce enough testosterone, the primary male sex hormone. This can lead to a variety of symptoms, including decreased, erectile dysfunction, fatigue, and muscle weakness. Male hypogonadism is typically treated with testosterone replacement therapy (TRT), which can be administered in several forms, such as gels, injections, and pellets.
Request For Free Sample Report of "Male Hypogonadism Market"@ https://www.persistencemarketresearch.com/samples/22303
The global male hypogonadism…
Male Origin Male Enhancement - Restore Testosterone, Best Reviews, Male Enhancem …
Male Origin Male Enhancement You need to go to your most unmistakable potential in the room, paying little mind to your age. Taking everything into account, you're a man. You ought to be OK at sex. Luckily, Male Origin Male Enhancement Male Enhancement can help with settling any sexual dysfunctions that are holding you down. For example, if you fight with unwinding when you undeniably shouldn't be limp, this can…
Libopro Male Enhance Review-Does Libopro Male Enhance Work-Complete Info
LiboPro Male Enhancement to an external site. Herbal is a herbal nutritional supplement that contains a effective mixture of the strongest natural ingredients that help you could Max out your performance. This supplement makes use of a natural composition as a way to assure you the safest results without Side Effects. This is the best quality manner right now to increase your sexual potential and revel in existence the way…
